Thirty-day readmission rates after PCI in a metropolitan center in Europe: Incidence and impact on prognosis

Journal of Cardiovascular Medicine

Volumn 16, Issue 3, 2015, Pages 238-245

  Moretti, Claudio ^a   D'Ascenzo, Fabrizio ^a   Omedè, Pierluigi ^a   Sciuto, Filippo ^a   Presutti, Davide Giacomo ^a   Di Cuia, Marco ^a   Colaci, Chiara ^a   Giusto, Federico ^a   Ballocca, Flavia ^a   Cerrato, Enrico ^a   Colombo, Francesco ^a   Gonella, Anna ^a   Giordana, Francesca ^a   Longo, Giada ^a   Vilardi, Ilaria ^a   Bertaina, Maurizio ^a   Orlando, Anna ^b   Andrini, Rita ^b   Ferrando, Alberto ^c   Di Nicolantonio, James J ^d   Zoccai, Giuseppe Biondi ^a   Sheiban, Imad ^a   Gaita, Fiorenzo ^a   more..

^a CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^b CSI Piemonte Direzione Salute Area Trattamento Dati   (Italy)

^c SC Programmazione e Controllo di Gestione   (Italy)

^d Wegmans Pharmacy   (United States)

Author keywords

30 day readmission; Metropolitan center; Percutaneous coronary intervention; Prognosis

Indexed keywords

ACUTE CORONARY SYNDROME; AGED; ARTICLE; EUROPE; FEMALE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL READMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; ITALY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ACUTE CORONARY SYNDROME; AGED; FEMALE; HUMANS; ITALY; MALE; PATIENT READMISSION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84925862310     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000136     Document Type: Article

References (41)

1. Kristensen SD, Fajadet J, Di Mario C, et al. Implementation of primary angioplasty in Europe: stent for life initiative progress report. EuroIntervention 2012;8:35-42.
2. Vranckx P, Farooq V, Garg S, et al. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting. Heart 2012;98:1424-1430.
3. Muthusamy P, Busman DK, Davis AT, Wohns DH. Assessment of clinical outcomes related to early discharge after elective percutaneous coronary intervention: COED PCI. Catheter Cardiovasc Interv 2013;81:6-13.
4. Rao SV, Kaltenbach LA, Weintraub WS, et al. Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients. JAMA 2011;306:1461-1467.
5. Presutti DG, D'Ascenzo F, Omedè P, et al. Percutaneous coronary intervention in nonagenarian: a meta-analysis of observational studies. J Cardiovasc Med (Hagerstown) 2013;14:773-779.
6. Barchielli A, Santoro GM, Balzi D, et al. Long-term prognosis after primary PCI in unselected patients with ST-elevation myocardial infarction. J Cardiovasc Med (Hagerstown) 2012;13:819-827.
7. Obama B. Securing the future of American healthcare. N Engl J Med 2012;367:1377-1381.
8. Romney M. Replacing Obamacare with real healthcare reform. N Engl J Med 2012;367:1377-1381.
9. Khawaja FJ, Shah ND, Lennon RJ, et al. Factors associated with 30-day readmission rates after percutaneous coronary intervention. Arch Intern Med 2012;172:112-117.
10. Hannan EL, Zhong Y, Krumholz H, et al. 30-day readmission for patients undergoing percutaneous coronary interventions in New York state. JACC Cardiovasc Interv 2011;4:1335-1342.
11. Jack BW, Chetty VK, Anthony D, et al. Reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med 2009;150:178-187.
12. Coleman EA, Parry C, Chalmers S, Min SJ. The care transitions intervention: results of a randomized controlled trial. Arch Intern Med 2006;166:1822-1828.
13. Patient Protection and Affordable Care Act of 2010. Pub L No. 111-148. 124 Stat 119.
14. Epstein AM. Paying for performance in the United States and abroad. N Engl J Med 2006;355:406-408.
15. Von Elm E, Altman DG, Egger M, et al., STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344-349.
16. Garg S, Sarno G, Garcia-Garcia HM, et al., ARTS-II Investigators. A new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score. Circ Cardiovasc Interv 2010;3:317-326.
17. Biondi-Zoccai G, Romagnoli E, Castagno D, et al. Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score. EuroIntervention 2012;8:359-367.
18. Thygesen K, Alpert JS, Jaffe AS, et al., Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-2567.
19. Testa L, Van Gaal WJ, Biondi Zoccai GG, et al. Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. QJM 2009;102:369-378.
20. Woudstra P, Grundeken MJ, Van De Hoef TP, et al. Prognostic relevance of PCI-related myocardial infarction. Nat Rev Cardiol 2013;10:231-236.
21. Biondi-Zoccai G, Romagnoli E, Agostoni P, et al. Are propensity scores really superior to standard multivariable analysis? Contemp Clin Trials 2011;32:731-740.
22. D'Ascenzo F, Cavallero E, Biondi-Zoccai G, et al. Use and misuse of multivariable approaches in interventional cardiology studies on drugeluting stents: a systematic review. J Interv Cardiol 2012;25:611-621.
23. Curtis JP, Schreiner G, Wang Y, et al. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients. J Am Coll Cardiol 2009;54:903-907.
24. Voss R, Gardner R, Baier R, et al. The care transitions intervention: translating from efficacy to effectiveness. Arch Intern Med 2011;171:1232-1237.
25. Chou WC, Cooney LM Jr, Van Ness PH, et al. Access to primary care for Medicare beneficiaries. J Am Geriatr Soc 2007;55:763-768.
26. Asplin BR, Rhodes KV, Levy H, et al. Insurance status and access to urgent ambulatory care follow-up appointments. JAMA 2005;294:1248-1254.
27. Conti A, Canuti E, Mariannini Y, et al. Clinical management of atrial fibrillation: early interventions, observation, and structured follow-up reduce hospitalizations. Am J Emerg Med 2012;30:1962-1969.
28. Ashton CM, Wray NP. A conceptual framework for the study of early readmission as an indicator of quality of care. Soc Sci Med 1996;43:1533-1541.
29. Hernandez AF, Granger CB. Prediction is very hard, especially about the future: comment on 'factors associated with 30-day readmission rates after percutaneous coronary intervention'. Arch Intern Med 2012;172:117-119.
30. Hernandez AF, Fonarow GC, Liang L, et al. The need for multiple measures of hospital quality: results from the Get with the Guidelines-Heart Failure Registry of the American Heart Association. Circulation 2011;124:712-719.
31. Cockburn J, Behan M, De Belder A, et al. Use of troponin to diagnose periprocedural myocardial infarction: effect on composite endpoints in the British Bifurcation Coronary Study (BBC ONE). Heart 2012;98:1431-1435.
32. Lansky AJ, Stone GW. Periprocedural myocardial infarction: prevalence, prognosis, and prevention. Circ Cardiovasc Interv 2010;3:602-610.
33. Tandjung K, Basalus MW, Muurman E, et al. Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stents. Catheter Cardiovasc Interv 2012;80:524-530.
34. Lindsey JB, Kennedy KF, Stolker JM, et al. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv 2011;4:474-480.
35. Herrmann J, Von Birgelen C, Haude M, et al. Prognostic implication of cardiac troponin T increase following stent implantation. Heart 2002;87:549-553.
36. Halfon P, Eggli Y, Prêtre-Rohrbach I, et al. Validation of the potentially avoidable hospital readmission rate as a routine indicator of the quality of hospital care. Med Care 2006;44:972-981.
37. Kansagara D, Englander H, Salanitro A, et al. Risk prediction models for hospital readmission: a systematic review. JAMA 2011;306:1688-1698.
38. Krumholz HM, Lin Z, Drye EE, et al. An administrative claims measure suitable for profiling hospital performance based on 30-day all-cause readmission rates among patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2011;4:243-252.
39. Ranucci M, Castelvecchio S, Menicanti L, et al. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation 2009;119:3053-3061.
40. Taglieri N, Dall'Ara G, Rapezzi C, et al. Predictors of complicated atherothrombotic lesions in non-ST segment acute coronary syndrome. J Cardiovasc Med (Hagerstown) 2013;14:430-437.
41. Hammill BG, Curtis LH, Fonarow GC, et al. Incremental value of clinical data beyond claims data in predicting 30-day outcomes after heart failure hospitalization. Circ Cardiovasc Qual Outcomes 2011;4:60-67.